Magnetic Device for Intestinal Anastomosis
(FLOWS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are on high-dose corticosteroids or other immunosuppressive treatments, you may not be eligible to participate.
How is the Flexagon SFM Device with OTOLoc treatment different from other treatments for intestinal anastomosis?
The Flexagon SFM Device with OTOLoc is unique because it uses magnetic compression to create a connection between intestinal sections without the need for staples or sutures, reducing the risk of inflammation and foreign body reactions. The magnetic rings are eventually expelled naturally, making the process less invasive and potentially lowering medical costs.12345
What is the purpose of this trial?
The primary objective of this trial is to investigate the safety and effectiveness of the Flexagon SFM system plus OTOLoc when used to create a small bowel anastomosis in subjects undergoing laparoscopic small bowel surgery.
Research Team
Erik Wilson, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Eligibility Criteria
This trial is for adults aged 22 or older who need laparoscopic small bowel surgery and can sign a consent form. They must have medical clearance, be non-smokers during the study, live close to the study center, and have an ASA score less than IV.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo small bowel anastomosis using the Flexagon SFM system plus OTOLoc
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Flexagon SFM Device with OTOLoc
Find a Clinic Near You
Who Is Running the Clinical Trial?
GI Windows, Inc.
Lead Sponsor